398,603views
00:00 / 00:00
Medicine and surgery
Antihistamines for allergies
Glucocorticoids
Coronary artery disease: Clinical (To be retired)
Heart failure: Clinical (To be retired)
Syncope: Clinical (To be retired)
Hypertension: Clinical (To be retired)
Hypercholesterolemia: Clinical (To be retired)
Peripheral vascular disease: Clinical (To be retired)
Leg ulcers: Clinical (To be retired)
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Antiplatelet medications
Hypersensitivity skin reactions: Clinical (To be retired)
Eczematous rashes: Clinical (To be retired)
Papulosquamous skin disorders: Clinical (To be retired)
Alopecia: Clinical (To be retired)
Hypopigmentation skin disorders: Clinical (To be retired)
Benign hyperpigmented skin lesions: Clinical (To be retired)
Skin cancer: Clinical (To be retired)
Diabetes mellitus: Clinical (To be retired)
Hyperthyroidism: Clinical (To be retired)
Hypothyroidism and thyroiditis: Clinical (To be retired)
Dizziness and vertigo: Clinical (To be retired)
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Gastroesophageal reflux disease (GERD): Clinical (To be retired)
Peptic ulcers and stomach cancer: Clinical (To be retired)
Diarrhea: Clinical (To be retired)
Malabsorption: Clinical (To be retired)
Colorectal cancer: Clinical (To be retired)
Diverticular disease: Clinical (To be retired)
Anal conditions: Clinical (To be retired)
Cirrhosis: Clinical (To be retired)
Breast cancer: Clinical (To be retired)
Laxatives and cathartics
Antidiarrheals
Acid reducing medications
Anemia: Clinical (To be retired)
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Pneumonia: Clinical (To be retired)
Urinary tract infections: Clinical (To be retired)
Skin and soft tissue infections: Clinical (To be retired)
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anti-mite and louse medications
Chronic kidney disease: Clinical (To be retired)
Kidney stones: Clinical (To be retired)
Urinary incontinence: Pathology review
ACE inhibitors, ARBs and direct renin inhibitors
PDE5 inhibitors
Adrenergic antagonists: Alpha blockers
Stroke: Clinical (To be retired)
Lower back pain: Clinical (To be retired)
Headaches: Clinical (To be retired)
Migraine medications
Asthma: Clinical (To be retired)
Chronic obstructive pulmonary disease (COPD): Clinical (To be retired)
Lung cancer: Clinical (To be retired)
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Joint pain: Clinical (To be retired)
Rheumatoid arthritis: Clinical (To be retired)
Lower back pain: Clinical (To be retired)
Anatomy clinical correlates: Clavicle and shoulder
Anatomy clinical correlates: Arm, elbow and forearm
Anatomy clinical correlates: Wrist and hand
Anatomy clinical correlates: Median, ulnar and radial nerves
Anatomy clinical correlates: Bones, joints and muscles of the back
Anatomy clinical correlates: Hip, gluteal region and thigh
Anatomy clinical correlates: Knee
Anatomy clinical correlates: Leg and ankle
Anatomy clinical correlates: Foot
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Glucocorticoids
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Non-biologic disease modifying anti-rheumatic drugs (DMARDs)
Osteoporosis medications
Urinary incontinence: Pathology review
0 / 3 complete
of complete
Laboratory value | Result |
Glucose | 118 mg/dL |
HbA1c | 6.9% |
Prostate-specific antigen (PSA)* | 3.6 ng/ml |
Anca-Elena Stefan, MD
Evan Debevec-McKenney
Marisa Pedron
Elizabeth Nixon-Shapiro, MSMI, CMI
In the Urology ward, two people are coming in. The first is Oleg, a 70 year old man who says that he frequently has to use the bathroom and also complains of a weak urinary stream. The second is Samantha, a 55 year old woman who says that she “pees” a little when she laughs. Samantha also has 2 children and both were born by vaginal delivery. Now, both these individuals seem to have urinary incontinence.
Urinary incontinence is a problem where the process of urination happens involuntarily, meaning that a person might urinate without intending to. This is particularly problematic because it affects a person’s personal hygiene as well as their social life in a way that can be very limiting.
Let’s talk about physiology real quick. Okay, so as urine flows from the kidneys into the bladder, the bladder starts to fill. Lining the bladder is a layer of transitional epithelium containing “umbrella cells”. These cells physically stretch out as the bladder fills, just like an umbrella opening up in slow-motion. This expansion is further aided by the relaxation of the muscular layer within the bladder’s walls, called the detrusor muscle. At some point, the bladder fills up with urine that will eventually exit the body through the urethra.
Now, the urethra is wrapped up in some muscles that can prevent urine from leaking out. The first one is the internal sphincter muscle, which is made of smooth muscle and is under involuntary control and typically opens up when the bladder is about half full. The second one is the external sphincter muscle, and it’s made of skeletal muscle and is under voluntary control. This is the reason that it’s possible to stop urine mid-stream by tightening up that muscle. Once urine has passed through the external sphincter muscle, it can no longer be stopped.
Urinary incontinence is a common condition that occurs when urine involuntarily leaks from the bladder, often through the internal and external sphincter muscles. There are several types of urinary incontinence, including urge incontinence, stress incontinence, and overflow incontinence.
Urge incontinence is typically caused by an overactive bladder, which can lead to sudden and strong urges to urinate that are difficult to control. Stress incontinence, on the other hand, is often due to increased pressure on the bladder, which can happen during physical activity, sneezing, or coughing. Overflow incontinence is caused by incomplete emptying of the bladder, leading to urine leakage due to bladder overfilling.
The treatment for urinary incontinence depends on the underlying cause and severity of the condition. Some common interventions include strengthening the external sphincter muscle by doing things like Kegel exercises, and catheterization or medications like alpha-blockers, which relax the smooth muscle to assist with urination.
Copyright © 2023 Elsevier, except certain content provided by third parties
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.